Jiaoyang Yin

Prof. Jiaoyang Yin


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2007 in Lung Cancer
Verified
Journal Article
Closed access
JYJiaoyang Yin
Jiaoyang Yin
UVUlla Vogel
Ulla Vogel
YMYegang Ma
Yegang Ma
RQRong Qi
Rong Qi
ZSZhongfu Sun
Zhongfu Sun
HWHuiwen Wang
Huiwen Wang

31 August 2006 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
PDF file
JYJiaoyang Yin
Jiaoyang Yin
UVUlla Vogel
Ulla Vogel
YMYegang Ma
Yegang Ma
LGLi Guo
Li Guo
HWHuiwen Wang
Huiwen Wang
RQRong Qi
Rong Qi

1 January 2009 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
JYJiaoyang Yin
Jiaoyang Yin
UVUlla Vogel
Ulla Vogel
YMYegang Ma
Yegang Ma
RQRong Qi
Rong Qi
HWHuiwen Wang
Huiwen Wang

1 January 2006 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
JYJiaoyang Yin
Jiaoyang Yin
UVUlla Vogel
Ulla Vogel
LGLi Guo
Li Guo
YMYegang Ma
Yegang Ma
HWHuiwen Wang
Huiwen Wang

5 May 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JYJiaoyang Yin
Jiaoyang Yin
CWChunhong Wang
Chunhong Wang
UVUlla Vogel
Ulla Vogel
YMYegang Ma
Yegang Ma
YZYing Zhang
Ying Zhang
SDShuai Du
Shuai Du
Lung cancer is a complex disease influenced by a variety of genetic and environmental factors. The cytokine interleukin 1 encoded by IL1B is an important mediator of the inflammatory response, and is involved in a variety of cellular activities. The effect of single nucleotide polymorphisms (SNP) at IL1B has been investigated in relation to cancer with inconsistent results. This Northeastern-Chinese case–control study involving 627 cases and 633 controls evaluated the role of three haplotype-tagging single nucleotide polymorphisms (htSNP) (rs1143633, rs3136558 and rs1143630) representing 95% of the common haplotype diversity across the IL1B gene and assessed interactions with IL1B, PPP1R13L, POLR1G and smoking duration in relation to lung cancer risk. The analyses of five genetic models showed associations with lung cancer risk for rs1143633 in the dominant model [adjusted-OR (95% CI) = 0.67 (0.52–0.85), P = 0.0012] and rs3136558 in the recessive model [adjusted-OR (95% CI) = 1.44 (1.05–1.98), P = 0.025]. Haplotype4 was associated with increased lung cancer risk [adjusted-OR (95% CI) = 1.55 (1.07–2.24), P = 0.021]. The variant G-allele of rs1143633 was protective in smoking sub-group of > 20 years. Using multifactor dimensionality reduction (MDR) analyses, we identified the three best candidate models of interactions and smoking-duration or IL1B rs1143633 as main effect. In conclusion, our findings suggest that IL1B SNP rs1143633 may associate with lower risk of lung cancer, confirming previously identified marker; IL1B SNP rs3136558 and haplotype4 consisting of IL1B htSNPs may associate with increasing risk of lung cancer; interactions of IL1B with POLR1G or PPP1R13L or smoking-duration, which is independent or combined, may involve in risk of lung cancer and lung squamous cell carcinoma.

1 July 2013 in Gene
Verified
Journal Article
Closed access
JYJiaoyang Yin
Jiaoyang Yin
LGLi Guo
Li Guo
CWChunhong Wang
Chunhong Wang
HWHuiwen Wang
Huiwen Wang
YMYegang Ma
Yegang Ma
YZYudan Zhao
Yudan Zhao